Zimmer Biomet Holdings EPS (Diluted) increased by 71.8% to $1.22 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 34.1%, from $0.91 to $1.22. Over 2 years (FY 2023 to FY 2025), EPS (Diluted) shows a downward trend with a -14.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher values indicate stronger profitability even when accounting for potential share dilution.
Calculated by dividing net income by the weighted-average number of common shares outstanding, assuming the conversion o...
Used by all public companies to provide a realistic view of earnings per share for investors.
eps_diluted| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.67 | $0.69 | $0.07 | $0.73 | $0.92 | $1.11 | $1.00 | $0.77 | $2.00 | $0.84 | $1.18 | $1.23 | $1.19 | $0.91 | $0.77 | $1.16 | $0.71 | $1.22 |
| QoQ Change | — | +3.0% | -89.9% | +942.9% | +26.0% | +20.7% | -9.9% | -23.0% | +159.7% | -58.0% | +40.5% | +4.2% | -3.3% | -23.5% | -15.4% | +50.6% | -38.8% | +71.8% |
| YoY Change | — | — | — | +9.0% | +33.3% | >999% | +37.0% | -16.3% | — | -24.3% | +18.0% | +59.7% | -40.5% | +8.3% | -34.7% | -5.7% | -40.3% | +34.1% |